Menu Search
Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Learn moreSubscribe now
Equities

Chemed Corp

CXM:DUS

Chemed Corp

Actions
  • Price (EUR)540.00
  • Today's Change-5.00 / -0.92%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 26 2024 11:31 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company operates through two segments: VITAS and the Roto-Rooter. VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Roto-Rooter provides plumbing, drain cleaning and water restoration services to both residential and commercial customers. Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. Its Water Restoration Services involve the remediation of water and humidity after a flood.

  • Revenue in USD (TTM)2.38bn
  • Net income in USD301.73m
  • Incorporated1970
  • Employees15.09k
  • Location
    Chemed Corp255 E. Fifth Street,, Suite 2600,CINCINNATI 45202United StatesUSA
  • Phone+1 (513) 762-6690
  • Fax+1 (302) 636-5454
  • Websitehttps://www.chemed.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.